ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,041, issued on Jan. 13, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Systems, devices, and methods for analyte sensor insertion" was invented by Vincent M. DiPalma (Oakland, Calif.), Phillip W. Carter (Oakland, Calif.), Udo Hoss (San Ramon, Calif.), Peter G. Robinson (Alamo, Calif.) and Andrew H. Naegeli (Walnut Creek, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor for sensing an analyte level in a bodily fluid of a subject. In various embodiments, applicators and components thereof are designed to reduce trauma to tissue o...